Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$224.73 - $338.64 $13.4 Million - $20.3 Million
-59,844 Reduced 89.66%
6,901 $1.71 Million
Q1 2022

May 12, 2022

SELL
$277.25 - $366.29 $2.26 Million - $2.99 Million
-8,169 Reduced 10.9%
66,745 $22.1 Million
Q4 2021

Feb 10, 2022

BUY
$300.63 - $371.35 $19.1 Million - $23.6 Million
63,664 Added 565.9%
74,914 $26.9 Million
Q3 2021

Nov 10, 2021

BUY
$310.19 - $376.2 $1.88 Million - $2.28 Million
6,067 Added 117.06%
11,250 $3.66 Million
Q2 2021

Aug 11, 2021

BUY
$262.71 - $351.17 $337,845 - $451,604
1,286 Added 33.0%
5,183 $1.62 Million
Q1 2021

May 12, 2021

BUY
$285.92 - $355.13 $47,462 - $58,951
166 Added 4.45%
3,897 $1.24 Million
Q4 2020

Feb 10, 2021

SELL
$251.88 - $324.2 $9,571 - $12,319
-38 Reduced 1.01%
3,731 $1.21 Million
Q3 2020

Nov 13, 2020

SELL
$255.22 - $317.0 $418,560 - $519,880
-1,640 Reduced 30.32%
3,769 $1.04 Million
Q2 2020

Aug 12, 2020

SELL
$141.4 - $257.09 $84,415 - $153,482
-597 Reduced 9.94%
5,409 $1.31 Million
Q1 2020

May 14, 2020

BUY
$130.51 - $196.01 $458,351 - $688,387
3,512 Added 140.82%
6,006 $872,000
Q4 2019

Feb 12, 2020

BUY
$159.31 - $223.54 $153,893 - $215,939
966 Added 63.22%
2,494 $425,000
Q3 2019

Nov 12, 2019

BUY
$175.89 - $279.23 $94,628 - $150,225
538 Added 54.34%
1,528 $272,000
Q2 2019

Aug 09, 2019

SELL
$250.96 - $284.94 $76,040 - $86,336
-303 Reduced 23.43%
990 $258,000
Q1 2019

May 15, 2019

SELL
$276.39 - $362.25 $3.79 Million - $4.96 Million
-13,702 Reduced 91.38%
1,293 $369,000
Q4 2018

Feb 14, 2019

BUY
$281.08 - $444.25 $3.42 Million - $5.41 Million
12,169 Added 430.61%
14,995 $4.87 Million
Q3 2018

Nov 13, 2018

BUY
$354.53 - $449.75 $204,563 - $259,505
577 Added 25.66%
2,826 $1.27 Million
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $625,379 - $1 Million
2,249 New
2,249 $920,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.